Favorable Evolution of a Patient with Thromboembolic Pulmonary Hypertension
, , , , e
17 mag 2017
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 17 mag 2017
Pagine: 94 - 98
DOI: https://doi.org/10.1515/arsm-2017-0017
Parole chiave
© by Irinel Raluca Parepa
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
We present a case of severe thromboembolic pulmonary hypertension in a patient with history of recurrent deep vein thrombosis and pulmonary restrictive disease due to pulmonary and vertebral tuberculosis in young adulthood. He was considered not eligible in the National Program for Primary Pulmonary Hypertension, being referred for thoracic surgery, but he was considered unfit for thrombendarterectomy. Despite guidelines, we administered him specific medical therapy (phosphodiesterase-5 inhibitors and endothelin receptor antagonists). His clinical evolution was satisfactory, with increasing effort tolerance and decreasing need for ambulatory oxigenotherapy.